Combined selective internal radiation therapy and 177Lu-PSMA-617 in patients with mCRPC and progressive liver metastases

Nuklearmedizin 2019; 58(02): 130-131
DOI: 10.1055/s-0039-1683546

Vorträge

Theranostik: NET und Radioembolisation

Georg Thieme Verlag KG Stuttgart · New York

R Seifert

¹University Hospital Münster, Department of Nuclear Medicine, Münster

,

A Bräuer

¹University Hospital Münster, Department of Nuclear Medicine, Münster

,

M Bögemann

²University Hospital Münster, Department of Urology, Münster

,

M Köhler

³University Hospital Münster, Department of Clinical Radiology, Münster

,

M Weckesser

¹University Hospital Münster, Department of Nuclear Medicine, Münster

,

K Rahbar

¹University Hospital Münster, Department of Nuclear Medicine, Münster